217 filings
Page 4 of 11
6-K
axz1gs49
17 May 22
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
8:19am
6-K
dggp99
9 May 22
Current report (foreign)
8:15am
6-K
3chsnna3q6sacw0g62
9 May 22
Current report (foreign)
8:06am
6-K
2exe3
31 Mar 22
Mereo BioPharma Reports Full Year 2021 Financial Results and Recent Highlights
4:18pm
6-K
q0luem q3
14 Mar 22
Current report (foreign)
10:05am
6-K
p7d7z6e3
1 Mar 22
Mereo BioPharma Announces Appointment of Anne Hyland to Board of Directors
9:55am
S-8
i1a ireibjn
13 Jan 22
Registration of securities for employees
4:31pm
6-K
hmh3ikr27qat ny9fzh
22 Dec 21
Alvelestat reported safe and well-tolerated in patients with COVID-19
7:45am
6-K
l3i5 q7f9oq0
30 Nov 21
Mereo BioPharma Reports Interim Data from ACTIVATE Phase 1b/2 Open Label Study of
7:51am
6-K
espe0q
4 Nov 21
Current report (foreign)
4:17pm
6-K
mcx0jratak7 19y
2 Nov 21
Current report (foreign)
4:16pm
6-K
11dxve9rjujf341l jjm
26 Oct 21
Current report (foreign)
4:16pm
6-K
y202o36m
26 Oct 21
Mereo BioPharma Receives U.S. Orphan Drug Designation for alvelestat in About Mereo BioPharma
10:07am
6-K
o1d xn5o3gpveq2up
1 Oct 21
Current report (foreign)
4:43pm
EFFECT
eof31l
1 Oct 21
Notice of effectiveness
12:15am
CORRESP
wo3x30n
29 Sep 21
Correspondence with SEC
12:00am
F-3/A
gpvhypfvto
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
UPLOAD
vbsm3ne9
21 Sep 21
Letter from SEC
12:00am
6-K
z820j
20 Sep 21
Mereo BioPharma Announces Appointment of Pierre Jacquet, M.D., Ph.D. to Board of Directors
8:20am